Cargando…

Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain

Centers for Disease Control and Prevention guidelines consider SARS-CoV-2 reinfection when sequential COVID-19 episodes occur >90 days apart. However, genomic diversity acquired over recent COVID-19 waves could mean previous infection provides insufficient cross-protection. We used genomic analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Grande, Cristina, Estévez, Agustín, Palomino-Cabrera, Rosalía, Molero-Salinas, Andrea, Peñas-Utrilla, Daniel, Herranz, Marta, Sanz-Pérez, Amadeo, Alcalá, Luis, Veintimilla, Cristina, Catalán, Pilar, Martínez-Laperche, Carolina, Alonso, Roberto, Muñoz, Patricia, Pérez-Lago, Laura, de Viedma, Darío García
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202887/
https://www.ncbi.nlm.nih.gov/pubmed/37130503
http://dx.doi.org/10.3201/eid2906.221696
Descripción
Sumario:Centers for Disease Control and Prevention guidelines consider SARS-CoV-2 reinfection when sequential COVID-19 episodes occur >90 days apart. However, genomic diversity acquired over recent COVID-19 waves could mean previous infection provides insufficient cross-protection. We used genomic analysis to assess the percentage of early reinfections in a sample of 26 patients with 2 COVID-19 episodes separated by 20–45 days. Among sampled patients, 11 (42%) had reinfections involving different SARS-CoV-2 variants or subvariants. Another 4 cases were probable reinfections; 3 involved different strains from the same lineage or sublineage. Host genomic analysis confirmed the 2 sequential specimens belonged to the same patient. Among all reinfections, 36.4% involved non-Omicron, then Omicron lineages. Early reinfections showed no specific clinical patterns; 45% were among unvaccinated or incompletely vaccinated persons, 27% were among persons <18 years of age, and 64% of patients had no risk factors. Time between sequential positive SARS-CoV-2 PCRs to consider reinfection should be re-evaluated.